Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
The Thyroid Gland01:23

The Thyroid Gland

7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Goiter01:27

Goiter

32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study.

ESC heart failure·2026
Same author

Biomarker study of pembrolizumab in patients with advanced rare cancers.

Cell reports. Medicine·2026
Same author

Neck adiposity on standard oncologic CT predicts radiation-induced carotid disease in oropharyngeal cancer.

Cardio-oncology (London, England)·2026
Same author

Cardiac resynchronization therapy in patients with cancer: A single cancer center experience.

Heart rhythm O2·2026
Same author

Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis.

Neuro-oncology·2026

Related Experiment Video

Updated: May 4, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.3K

Total thyroidectomy as primary definitive treatment for Graves' hyperthyroidism.

Samuel Snyder1, Cara Govednik, Terry Lairmore

  • 1Department of Surgery, Scott & White Healthcare, The Texas A&M Health Science Center College of Medicine, Temple, Texas.

The American Surgeon
|December 20, 2013
PubMed
Summary

Total thyroidectomy (TT) is a safe and effective treatment for Graves' disease (GD). While patients with GD had slightly higher blood loss and risk of hypoparathyroidism, TT offers a rapid cure and can be considered first-line therapy.

More Related Videos

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

284
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.8K

Related Experiment Videos

Last Updated: May 4, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.3K
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

284
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.8K

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Thyroid Surgery

Background:

  • Graves' disease (GD) is a common cause of hyperthyroidism.
  • Total thyroidectomy (TT) is a treatment option for hyperthyroidism.
  • The efficacy and safety of TT for GD compared to other thyroid conditions require further investigation.

Purpose of the Study:

  • To compare perioperative outcomes of TT for Graves' disease (GD) versus other benign thyroid diseases.
  • To evaluate the potential of TT as a first-line therapy for GD.

Main Methods:

  • Retrospective analysis of 780 patients undergoing TT for benign thyroid disease between March 2003 and December 2009.
  • Patients were categorized into three groups: GD (n=203), other hyperthyroidisms (n=56), and other benign diseases (n=521).
  • Comparison of demographics, blood loss, operative time, complications, and hospitalization across groups.

Main Results:

  • No significant differences in operative time or hospitalization were observed.
  • Patients with GD were younger and experienced more blood loss and permanent hypoparathyroidism compared to other groups.
  • No permanent recurrent laryngeal nerve injuries occurred in the GD group; transient injuries were comparable across groups.
  • Eighty percent of TTs for GD were performed as same-day outpatient procedures.

Conclusions:

  • Total thyroidectomy (TT) is a safe and effective treatment for Graves' disease (GD).
  • Despite slightly increased risks of blood loss and hypoparathyroidism, TT provides a rapid cure for GD.
  • TT should be considered a reasonable first-line therapy for selected patients with Graves' hyperthyroidism.